Table 3.
Study | Nevi included |
BRAF mutations |
NRAS mutations |
---|---|---|---|
(Pollock et al., 2003) | Dysplastic nevi | 4/5(80%) | -- |
(Papp et al., 2005) | Dysplastic nevi | 4/18(22%) | -- |
(Uribe et al., 2006) | Atypical nevi | 13/21(61.9%) | -- |
(Saroufim et al., 2014) | Dysplastic nevi | 63/125(55.8%) | -- |